5-methylcytosine has been researched along with Cancer of Prostate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ci, W; Huang, C; Qi, J; Shi, Y; Tan, Y; Wang, J; Zhang, J; Zhang, Q | 1 |
| Aggarwal, R; Alumkal, JJ; Annala, M; Ashworth, A; Beer, TM; Bergamaschi, A; Bjartell, A; Bose, R; Boutros, PC; Chen, S; Chen, WS; Chesner, L; Chi, KN; Chou, J; Cui, XL; Evans, CP; Feng, FY; Fong, L; Foye, A; Fraser, M; Gilbert, LA; Gleave, M; Haffner, MC; He, C; He, HH; Herberts, C; Hua, JT; Huang, FW; Huang, J; Lang, JM; Lara, PN; Levy, S; Li, H; Lloyd, P; Lundberg, A; Luo, J; Mahajan, NP; Maher, CA; Maheshwari, A; Maurice-Dror, C; McCarthy, E; Moreno-Rodriguez, T; Morgans, AK; Ng, SWS; Ning, Y; Perry, MD; Petricca, J; Phillips, T; Posadas, EM; Quigley, DA; Reiter, RE; Rettig, MB; Shrestha, R; Sjöström, M; Small, EJ; Thomas, GV; Tran, PT; Witte, ON; Wyatt, AW; Ye, W; Zhang, M; Zhao, SG; Zoubeidi, A; Zwart, W | 1 |
| Arda-Pirincci, P; Caglayan, M; Fatma Karaman, E; Ozal-Coskun, C; Ozden, S; Sancar-Bas, S | 1 |
| Chen, Z; Fan, M; Feng, Y; Liang, B; Luo, G; Shi, J; Sun, Y; Wang, K; Xu, X; Yu, M; Zhuang, Q | 1 |
| Lin, B; Ren, G; Wang, L | 1 |
| Claessens, F; Helsen, C; Joniau, S; Lynch, AG; Massie, CE; Moris, L; Prekovic, S; Smeets, E; Van den Broeck, T | 1 |
| Belengeanu, V; Grelus, A; Ioiart, I; Miklos, I; Nica, DV; Popescu, C | 1 |
| Borre, M; Høyer, S; Lynnerup, AS; Storebjerg, TM; Strand, SH; Sørensen, KD; Ørntoft, TF | 1 |
| Berg, KD; Borre, M; Brasso, K; Høyer, S; Kristensen, G; Røder, MA; Strand, SH; Sørensen, KD; Toft, BG | 1 |
| Plass, C; Weichenhan, D | 1 |
| Clark, SJ; Valdés-Mora, F | 1 |
| Fujimura, T; Hayashizaki, Y; Homma, Y; Inoue, S; Misawa, A; Suzuki, T; Takagi, K; Takahashi, S; Takayama, K; Urano, T | 1 |
| Bistulfi, G; Matsui, S; Smiraglia, DJ; Vandette, E | 1 |
| Gu, Y; Hou, W; Li, F; Li, H; Li, Q; Lin, W; Song, Y; Sun, H; Yang, B; Zhang, F; Zhang, L | 1 |
| Argani, P; Chaux, A; De Marzo, AM; Esopi, DM; Gerber, J; Haffner, MC; Iacobuzio-Donahue, C; Meeker, AK; Nelson, WG; Netto, GJ; Pellakuru, LG; Toubaji, A; Yegnasubramanian, S | 1 |
| Gertych, A; Oh, JH; Tajbakhsh, J; Wawrowsky, KA; Weisenberger, DJ | 1 |
| Brothman, AR; Cui, J; Herrick, J; Isaac, J; Maxwell, TM; Murphy, KJ; Rohr, LR; Speights, VO; Swanson, G | 1 |
| Bedford, MT; van Helden, PD | 1 |
3 review(s) available for 5-methylcytosine and Cancer of Prostate
| Article | Year |
|---|---|
The role of TET-mediated DNA hydroxymethylation in prostate cancer.
Topics: 5-Methylcytosine; Animals; DNA Methylation; Epigenesis, Genetic; Humans; Male; Models, Biological; Prostatic Neoplasms; Proto-Oncogene Proteins | 2018 |
The evolving epigenome.
Topics: 5-Methylcytosine; Chromosomal Proteins, Non-Histone; Computational Biology; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Male; MicroRNAs; Organ Specificity; Prostatic Neoplasms; RNA, Untranslated; SMARCB1 Protein; Transcription Factors | 2013 |
Prostate cancer epigenetic biomarkers: next-generation technologies.
Topics: 5-Methylcytosine; Biomarkers; DNA Methylation; Epigenesis, Genetic; High-Throughput Nucleotide Sequencing; Histones; Humans; Male; MicroRNAs; Prostatic Neoplasms | 2015 |
15 other study(ies) available for 5-methylcytosine and Cancer of Prostate
| Article | Year |
|---|---|
Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways.
Topics: 5-Methylcytosine; Ascorbic Acid; Carcinogenesis; DNA; DNA Methylation; Fibrin; Humans; Magnesium; Male; Phosphates; Prostatic Neoplasms; Urogenital Neoplasms | 2022 |
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Topics: 5-Methylcytosine; Biopsy; Humans; Male; Prostate; Prostatic Neoplasms | 2022 |
Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells.
Topics: 5-Methylcytosine; Benzhydryl Compounds; Cell Line, Tumor; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Down-Regulation; Endocrine Disruptors; Epigenesis, Genetic; Gene Expression; Histone Code; Humans; Male; PC-3 Cells; Phenols; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Tissue Inhibitor of Metalloproteinase-3; Tumor Suppressor Proteins | 2019 |
Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Movement; DNA Methylation; HEK293 Cells; Humans; Male; Mixed Function Oxygenases; Neoplasm Invasiveness; PC-3 Cells; Prostatic Neoplasms; Proto-Oncogene Proteins; Resveratrol; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Up-Regulation | 2020 |
Expression of 5-methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence.
Topics: 5-Methylcytosine; Datasets as Topic; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Models, Genetic; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; ROC Curve; Tumor Microenvironment | 2021 |
Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study.
Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Humans; Leukocytes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms | 2017 |
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
Topics: 5-Methylcytosine; Adult; Aged; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Receptors, Estrogen; Tissue Array Analysis | 2018 |
5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors.
Topics: 5-Methylcytosine; Aged; Cohort Studies; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prostatectomy; Prostatic Neoplasms; ROC Curve; Transcriptional Regulator ERG | 2019 |
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
Topics: 5-Methylcytosine; Aged; Androgens; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cytosine; Dioxygenases; Disease Progression; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hepatocyte Nuclear Factor 3-alpha; Humans; Hydroxylation; Immunohistochemistry; Male; Mice, Inbred BALB C; MicroRNAs; Middle Aged; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, RNA; TOR Serine-Threonine Kinases | 2015 |
Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells.
Topics: 5-Methylcytosine; Animals; Blotting, Western; Cell Line, Tumor; Chromatography, High Pressure Liquid; CpG Islands; DNA Damage; DNA Methylation; Epigenesis, Genetic; Folic Acid Deficiency; Male; Mice; Prostatic Neoplasms | 2010 |
Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Disease Progression; DNA Methylation; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Grading; Prognosis; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differentiation; Colonic Neoplasms; Cytosine; Down-Regulation; Embryo, Mammalian; Female; Gestational Age; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Stem Cells | 2011 |
3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models.
Topics: 5-Methylcytosine; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Survival; Cytidine; DNA Methylation; Humans; Liver Neoplasms; Male; Phenotype; Prostatic Neoplasms | 2013 |
Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?
Topics: 5-Methylcytosine; Aged; Densitometry; DNA Methylation; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Models, Biological; Prostatic Neoplasms; Treatment Outcome | 2005 |
Hypomethylation of DNA in pathological conditions of the human prostate.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA; Humans; Male; Mathematics; Methylation; Prostatic Hyperplasia; Prostatic Neoplasms | 1987 |